Long-term effect of antibodies against infused alpha-galactosidase A in Fabry disease on plasma and urinary (lyso)Gb3 reduction and treatment outcome - Rombach, S M; Aerts, J M; Poorthuis, B J (PLoS One, 2012)
, et al.